Taipei City, Taiwan

Chuan-Ching Yang

This inventor holds 2 USPTO granted patents. Top assignee: Gongwin Biopharm Co., Ltd. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chuan-Ching Yang. Retrieved from https://idiyas.com/inventor/chuan-ching-yang-5y5hubf9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0


Company Filing History:


Years Active: 2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Chuan-Ching Yang: Inventor in Cancer Research

Introduction

Chuan-Ching Yang is an inventor based in Taipei City, Taiwan. His work includes pharmaceutical research focused on benzenesulfonamide derivatives and their potential applications in cancer treatment.

Latest Patents

Yang is associated with 2 patents, including the following inventions:

- **Benzenesulfonamide Derivatives and Method for Treating Cancer.** This invention describes benzenesulfonamide derivatives, or their pharmaceutically acceptable salts, and a method for treating cancer using a pharmaceutical composition containing these compounds and suitable carriers.

- **Benzenesulfonamide Derivatives and Method for Modulating Lipid Raft.** This invention concerns a benzenesulfonamide derivative that can modulate the integrity of lipid rafts in cancer cells. It also describes using the derivative to prevent or treat conditions that may be improved by changing lipid raft integrity.

Career Highlights

Yang’s patent work reflects an emphasis on developing compounds with potential therapeutic uses. He is associated with Gongwin Biopharm Co., Ltd., where his research is connected to pharmaceutical innovation.

Collaborations

Yang’s listed coworkers include Mao-Yuan Lin and Shun-Chi Wu. Their names appear alongside his work in the context of pharmaceutical inventions.

Conclusion

Chuan-Ching Yang’s patents focus on benzenesulfonamide derivatives and their potential roles in cancer treatment and lipid raft modulation, highlighting his contributions to pharmaceutical innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…